Carregant...
Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review
BACKGROUND: Novel tuberculosis (TB) drugs and the need to treat drug-resistant tuberculosis (DR-TB) are likely to bring about substantial transformations in TB treatment in coming years. An evidence base for cost and cost-effectiveness analyses of these developments is needed. OBJECTIVE: Our objecti...
Guardat en:
| Publicat a: | Pharmacoeconomics |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4559093/ https://ncbi.nlm.nih.gov/pubmed/25939501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-015-0279-6 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|